Literature DB >> 4264561

Chemotherapy of gastrointestinal cancer.

I H Krakoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4264561     DOI: 10.1002/1097-0142(197212)30:6<1600::aid-cncr2820300628>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

Review 1.  Obstacles to the improvement of radiotherapy of rectal cancer.

Authors:  M J Peckham
Journal:  Proc R Soc Med       Date:  1973-12

Review 2.  Tumour immunology and the gut.

Authors:  K C Calman
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

3.  Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration.

Authors:  N Chirstophidis; F J Vajda; I Lucas; O Drummer; W J Moon; W J Louis
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.

Authors:  Kathryn M Camacho; Stefano Menegatti; Douglas R Vogus; Anusha Pusuluri; Zoë Fuchs; Maria Jarvis; Michael Zakrewsky; Michael A Evans; Renwei Chen; Samir Mitragotri
Journal:  J Control Release       Date:  2016-03-24       Impact factor: 9.776

5.  Approving cancer treatments based on endpoints other than overall survival: an analysis of historical data using the PACE Continuous Innovation Indicators™ (CII).

Authors:  Neon Brooks; Mario Campone; Silvia Paddock; Scott Shortenhaus; David Grainger; Jacqueline Zummo; Samuel Thomas; Rose Li
Journal:  Drugs Context       Date:  2017-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.